Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells.
The small G-protein KRAS is crucial for mediating gonadotropin-induced events associated with ovulation. However, constitutive expression of KrasG12D in granulosa cells disrupted normal follicle development leading to the persistence of abnormal follicle-like structures containing nonmitotic cells. To determine what factors mediate this potent effect of KrasG12D, gene profiling analyses were done. We also analyzed KrasG12D;Cyp19-Cre and KrasG12;Pgr-Cre mutant mouse models that express Cre prior to or after the initiation of granulosa cell differentiation, respectively. KrasG12D induced cell cycle arrest in granulosa cells of the KrasG12D;Cyp19-Cre mice but not in the KrasG12D;Pgr-Cre mice, documenting the cell context-specific effect of KrasG12D. Expression of KrasG12D silenced the Kras gene, reduced cell cycle activator genes, and impaired the expression of granulosa cell and oocyte-specific genes. Conversely, levels of PTEN and phosphorylated p38 mitogen-activated protein kinase (MAPK) increased markedly in the mutant granulosa cells. Because disrupting Pten in granulosa cells leads to increased proliferation and survival, Pten was disrupted in the KrasG12D mutant mice. The Pten/Kras mutant mice were infertile but lacked granulosa cell tumors. By contrast, the Ptenfl/fl;KrasG12D;Amhr2-Cre mice developed aggressive ovarian surface epithelial cell tumors that did not occur in the Ptenfl/fl;KrasG12D;Cyp19-Cre or Ptenfl/fl;KrasG12D;Pgr-Cre mouse strains. These data document unequivocally that Amhr2-Cre is expressed in and mediates allelic recombination of oncogenic genes in ovarian surface epithelial cells. That KrasG12D/Pten mutant granulosa cells do not transform but rather undergo cell cycle arrest indicates that they resist the oncogenic insults of Kras/Pten by robust self-protecting mechanisms that silence the Kras gene and elevate PTEN and phosphorylated p38 MAPK.
Fan
Heng-Yu
HY
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Liu
Zhilin
Z
Paquet
Marilene
M
Wang
Jinrong
J
Lydon
John P
JP
DeMayo
Francesco J
FJ
Richards
JoAnne S
JS
D000818:Animals; D002453:Cell Cycle / Q000235:genetics; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology*; D005260:Female; D011905:Genes, ras; D006107:Granulosa Cells / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D016297:Mutagenesis, Site-Directed; D009154:Mutation / Q000502:physiology; D009928:Organ Specificity / Q000235:genetics; D010053:Ovary / Q000378:metabolism / Q000473:pathology; D051059:PTEN Phosphohydrolase / Q000235:genetics* / Q000378:metabolism; D010766:Phosphorylation; D016283:Proto-Oncogene Proteins p21(ras) / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
D048051:p38 Mitogen-Activated Protein Kinases; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse; C495971:Hras protein, mouse; D016283:Proto-Oncogene Proteins p21(ras)
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9
16849428
Nat Genet. 2004 Jun;36(6):653-9
15156143
Mol Endocrinol. 2008 Sep;22(9):2128-40
18606860
Cancer Cell. 2004 Apr;5(4):375-87
15093544
Nat Genet. 2007 Jun;39(6):741-9
17468757
Curr Opin Cell Biol. 2001 Dec;13(6):748-53
11698192
Differentiation. 2008 Dec;76(10):1081-92
18637025
Mol Endocrinol. 2007 Aug;21(8):1940-57
17536007
Mol Cell Biol. 2003 Dec;23(24):9375-88
14645547
Cancer Cell. 2007 Apr;11(4):321-33
17418409
Nat Med. 2005 Jan;11(1):63-70
15619626
Cancer Treat Res. 2002;107:293-302
11775457
Cancer Cell. 2006 Dec;10(6):459-72
17157787
Mol Cell Biol. 2008 Mar;28(5):1770-82
18172011
Trends Endocrinol Metab. 2000 Oct;11(8):309-14
10996525
J Biol Chem. 2004 May 7;279(19):19431-40
14982927
Genesis. 2005 Feb;41(2):58-66
15682389
Carcinogenesis. 2008 Nov;29(11):2062-72
18687666
J Clin Oncol. 2004 Jul 15;22(14):2954-63
15254063
Clin Cancer Res. 2006 Mar 1;12(5):1593-8
16533786
Nature. 2007 Oct 25;449(7165):1073-7
17960246
Recent Prog Horm Res. 1995;50:223-54
7740159
Cancer Res. 2003 Mar 15;63(6):1389-97
12649204
Cell. 1997 Mar 7;88(5):593-602
9054499
Biol Reprod. 1995 Jul;53(1):103-9
7669840
Nature. 2001 Apr 26;410(6832):1111-6
11323676
Cancer Res. 2006 Sep 15;66(18):8949-53
16982732
Cell. 2007 Jun 1;129(5):957-68
17540175
PLoS Biol. 2008 Dec 2;6(12):2853-68
19053174
Nat Genet. 2004 Jun;36(6):647-52
15156142
Nat Genet. 1998 Aug;19(4):348-55
9697695
Genes Cells. 2003 Feb;8(2):131-44
12581156
Nat Genet. 2002 Nov;32(3):408-10
12368913
Mol Cell. 2007 Jul 6;27(1):107-19
17612494
Trends Cell Biol. 2003 Sep;13(9):478-83
12946627
Mol Endocrinol. 2006 Jun;20(6):1300-21
16455817
Nature. 1992 Nov 26;360(6402):313-9
1448148
Science. 2009 May 15;324(5929):938-41
19443782
Mol Endocrinol. 2006 Dec;20(12):3308-20
16973759
Mol Endocrinol. 2000 Aug;14(8):1283-300
10935551
Mol Cell Endocrinol. 2000 May 25;163(1-2):61-6
10963875
Reprod Biol Endocrinol. 2003 Oct 07;1:67
14613552
Science. 2005 Aug 5;309(5736):886-7
16081723
Nat Cell Biol. 2007 May;9(5):493-505
17450133
Mol Cell. 2007 Jul 20;27(2):176-7
17643366
Genesis. 2002 Feb;32(2):148-9
11857804
Development. 2008 Jun;135(12):2127-37
18506027
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12469-73
18711140
Biochim Biophys Acta. 2000 Feb 14;1470(1):M21-35
10656987
Int J Gynecol Pathol. 2008 Apr;27(2):151-60
18317228